<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

Tim Jeavons

Director, European Orthopaedic Content & Sales 24+ years’ experience in Orthopedics with experience in Trauma, Extremities, and Orthobiologics. Previously held senior global marketing positions at Stryker and DePuy Synthes. Tim is based in Geneva, Switzerland.

Recent Posts

2 min read

COVID Consequences in 2021: The European Trauma & Extremities Markets

By Tim Jeavons on 4/20/21 7:45 AM

SmartTRAK outlines consequences COVID-19 is expected to have on the European Trauma & Extremities Market

Twenty-five years of orthopedic business planning has taught me to monitor certain non-business factors when setting goals. Trends in weather patterns, age demographics, lifestyle and activities can have a direct influence on market growth. In 2020, the COVID-19 pandemic negatively impacted the European market with the shutdown of various countries and the ensuing changes in lifestyle such as reduced travel, work and sporting activities. In 2020, SmartTRAK predicted the European Trauma market fell by around 25% with extremities at nearly -50% in the midst of COVID-19 lockdowns. Similar market pressures are also expected during 2021.


Download the complete  "European Trauma & Extremities: COVID Consequences in  2021" article

Continue Reading
3 min read

SmartTRAK Start-Up Spotlight: OrthoXel

By Tim Jeavons on 2/21/19 1:30 PM

OrthoXel is an orthopaedic trauma device company focused on evolving fracture fixation through evidence-based biomechanical implant design. The Company thoughtfully designed its flagship Apex Tibial and Femoral Nails with a focus on fundamental principles of bone healing, all while keeping the surgeon’s needs in mind. Every OrthoXel product features innovative locking modes not found in any other implant system on the market and all are meticulously designed and engineered to produce the best possible clinical results for every patient.  

Topics: Orthopedics
Continue Reading

    Recent Articles